Plaque Psoriasis
📧 Sign up to get email alerts when something new happens for Plaque Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
A Phase 3 clinical trial is evaluating the effect of Bimekizumab on gene expression biomarkers in adults with moderate to severe plaque psor…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of D-2570 in the Treatment of Moderate to Severe Plaque Psoriasis. [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of D-2570 for moderate to severe plaque psoriasis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]
This clinical trial update describes a Phase 3 study evaluating the pharmacokinetics, safety, and effectiveness of certolizumab pegol (Cimzi…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis [Phase 2]
A Phase 2 dose-ranging trial evaluating ORKA-002 in adults with moderate-to-severe plaque psoriasis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Clinical Study on the Medical Devices PROXERA PSOMED 20 and PROXERA PSOMED 40 for the Treatment of Plaque Psoriasis and Non-pustular Palmoplantar Psoriasis [NA]
Clinical trial update for PROXERA PSOMED 20 and PROXERA PSOMED 40 devices evaluating treatment of plaque psoriasis and non-pustular palmopla…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis [Phase 2]
Open-label extension study update for ORKA-001 in plaque psoriasis (Phase 2), currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of RSS0393 Ointment in Adult Patients With Plaque Psoriasis. [Phase 3]
A Phase III multicenter, randomized, double-blind, placebo-controlled trial will evaluate the efficacy and safety of RSS0393 ointment in adu…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK) [Phase 3]
Phase 3 long-term safety study comparing deucravacitinib with ustekinumab in adults with plaque psoriasis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO) [Phase 4]
Phase 4 clinical trial evaluating the effectiveness of tirzepatide after initiating ixekizumab in adults with moderate-to-severe plaque psor…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects [Phase 3]
Phase 3 trial update for tapinarof in pediatric plaque psoriasis; the study is active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis
This clinical trial registry entry describes a study to evaluate changes in quality of life for adults with moderate-to-severe plaque psoria…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study to Evaluate Comparative Efficacy and Safety of Guselkumab in High-dose and Extended-interval Versus Standard-dose in Chinese Participants of Moderate-to-severe Plaque Psoriasis [NA]
This clinical trial is evaluating high-dose and extended-interval guselkumab regimens compared with standard-dose in Chinese participants wi…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Observational Study to Evaluate Deucravacitinib in Patients With Moderate Plaque Psoriasis in China
An observational study in China evaluating Deucravacitinib for moderate plaque psoriasis; the trial is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis [Phase 2, Phase 3]
This update reports a pediatric Phase 2/3 study of tildrakizumab for chronic plaque psoriasis, which is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
A Phase 3 clinical trial update on JNJ-77242113 comparing it with placebo and ustekinumab in adults with moderate to severe plaque psoriasis…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis [Phase 3]
This Phase 3 clinical trial compares the efficacy and safety of bimekizumab versus ustekinumab in children and adolescents aged 6 to under 1…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
Phase 3 clinical trial update for JNJ-77242113 in adolescents and adults with moderate to severe plaque psoriasis, currently active but not …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Safety Study of Ustekinumab in the Treatment of Pediatric Participants Aged 6 Years and Older With Moderate to Severe Plaque Psoriasis
This clinical trial update indicates that Janssen-Cilag International NV's safety study of ustekinumab in pediatric participants aged 6 year…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Phase 3 Clinical Study of QL2106 Injection [Phase 3]
A Phase 3 clinical study of QL2106 Injection for plaque psoriasis is listed as not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis [Phase 3]
A Phase 3 long-term study of Zasocitinib in children and teenagers with plaque psoriasis is currently recruiting. The sponsor is Takeda.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers
Clinical trial update notes ongoing sample collection from participants with acne, atopic dermatitis, chronic hand eczema, hidradenitis supp…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis [Phase 2]
Phase 2 dose-ranging study of ORKA-001 in adults with moderate-to-severe plaque psoriasis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: A Study of Switching to Picankibart in Chinese Patients With Plaque Psoriasis With an Inadequate Response to Interleukin-17 Monoclonal Antibody Therapy [Phase 3]
A Phase 3 clinical trial evaluating switching to Picankibart in Chinese patients with plaque psoriasis who had an inadequate response to IL-…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Metformin Combined With Secukinumab for Moderate-to-Severe Plaque Psoriasis in Overweight or Obese Chinese Patients [Phase 4]
A Phase 4 clinical trial is evaluating the combination of Metformin and Secukinumab for moderate-to-severe plaque psoriasis in overweight or…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet) [Phase 3]
Phase 3 clinical trial update assessing JNJ-77242113 for plaque psoriasis involving special areas (scalp, genital, palms, and/or soles), cur…